Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID‐19 infected patients-Reference-Cited by-同舟云学术

Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID‐19 infected patients

Published:2020-06-09 Issue:1 Volume:190 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lanza Francesco¹^ORCID,Seghatchian Jerard²

Affiliation:

1. Hematology Unit Romagna Transplant Network Ravenna Hospital & University of Ferrara‐I London UK

2. International Consultancy in Strategic Advices on Safety Improvements of Blood‐Derived Bioproducts and Suppliers Quality Audit/Inspection London UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16814

Reference10 articles.

1. Ebola virus convalescent blood products: Where we are now and where we may need to go

2. WHO.Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion as an empirical treatment during outbreaks. 2014.2020. Available from:http://apps.who.int/iris/rest/bitstreams/604045/retrieve(accessed Feb 20 2020).

3. The convalescent sera option for containing COVID-19

4. Convalescent plasma as a potential therapy for COVID-19

5. Convalescent plasma, an apheresis research project by targeting and motivating the fully recovered COVID 19 patients: a rousing message of clinical benefits to both donors /recipients alike;Seghatchian J;Transfus Apher Sci,2020

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet Parameters and Interleukin 6 as Predictors of Disease Severity and Outcomes Amongst Hospitalised Coronavirus Disease-19 Patients;Malaysian Journal of Medicine and Health Sciences;2023-12-16

2. Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates;Viruses;2023-03-15

3. Thrombocytopenia and clinical outcomes among patients with COVID‐19 disease: A cohort study;Health Science Reports;2023-02

4. Effect of convalescent plasma therapy on mortality in moderate-to-severely Ill COVID-19 patients;Transfusion and Apheresis Science;2022-12

5. Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron;Transfusion and Apheresis Science;2022-12